BACTERIOLOGICAL PROFILE OF STAPHYLOCOCCUS AUREUS: A TEACHING HOSPITAL BASED STUDY

H. GHOGARE¹, S. HATKAR²*
¹Department of Microbiology, MGM Medical College, Aurangabad, 431003, MGM Institute of Health Sciences, Navi Mumbai, 410209, Maharashtra, India
²Department of Microbiology, SMBT Medical College, Nashik, 422403, Maharashtra University of Health Sciences, Nashik, 422004, Maharashtra, India
* Corresponding Author : sunilhatkar25@gmail.com

Received : 14-10-2018     Accepted : 27-10-2018     Published : 30-10-2018
Volume : 10     Issue : 10       Pages : 1392 - 1394
Int J Microbiol Res 10.10 (2018):1392-1394

Keywords : Staphylococcus aureus, MRSA
Conflict of Interest : None declared
Acknowledgements/Funding : Authors are thankful to MGM Medical College, Aurangabad, 431003, MGM Institute of Health Sciences, Navi Mumbai, 410209, India
Author Contribution : All authors equally contributed

Background: Multidrug resistant Staphylococcus aureus is major cause of serious from of infection, especially in hospital acquired infection. The increasing incidence of infections due to methicillin resistance staphylococci, reliable & accurate testing of methicillin resistance is crucial for both antimicrobial therapy and infection control. Materials and methods: All the clinical specimens received in the department of microbiology were subjected to culture and sensitivity of the pathogen as per standard guidelines. Cefoxitin disc was used to rule out methicillin resistant Staphylococcus aureus (MRSA) and the D-test was used to for the detection of inducible clindamycin resistant Staphylococcus aureus. Results: A total of 392 Staphylococcus aureus isolated from various clinical samples. Majority of pathogen was isolated from pus samples (52.6%) followed by sputum (14.8%), Blood (14.5%) and 7.1% from endotracheal secretion. Out of which 307(78.3%) isolates were MRSA, majority of isolates were sensitive to linezolid (71.7) followed by Amikacin(65.8%) and Doxycyclin(65.3%). Inducible resistant was noted in 46(11.7%) of isolates. Conclusion: The resistance pattern varies from different geographical area, hence continuous study on Staphylococcus aureus is crucial and local data related to pattern of infection can be useful to deal with serious form of infection.

1. Munita J. M., Arias C. A. (2016) Microbiology spectrum, 4(2).
2. Montgomery C. P., David M. Z., Daum R. S. (2015) Current opinion in infectious diseases, 28(3), 253.
3. Ki V., Rotstein C. (2008) Canadian Journal of Infectious Diseases and Medical Microbiology, 19(2), 173-84.
4. Green B.N., Johnson C.D., Egan J.T., Rosenthal M., Griffith E.A., Evans M.W. (2012) Journal of chiropractic medicine, 11(1), 64-76.
5. Stilianakis N.I., Drossinos Y. (2010) Journal of the Royal Society Interface, 7(50),1355-66.
6. Sunil Hatkar, Som Lakhani, Sucheta Lakhani, Lakhani J.D. (2018) Annals of Microbiology and Infectious Diseases, 1(3),9-16.
7. Harish Ghogare, Sunil Hatkar (2018) International journal of Current Microbiology and Applied Sciences, 7(10),1261-68.
8. Layer F., Ghebremedhin B., Moder K.A., König W., König B. (2006) Journal of clinical microbiology, 44(8),2824-30.
9. Harkins C.P., Pichon B., Doumith M., Parkhill J, Westh H., Tomasz A., de Lencastre H., Bentley S.D., Kearns A.M., Holden M.T. (2017) Genome biology,18(1),130.
10. Bæk K.T., Gründling A., Mogensen R.G., Thøgersen L., Petersen A., Paulander W., Frees D. (2014) Antimicrobial agents and chemotherapy, AAC-02802.
11. Perovic O., Singh-Moodley A., Govender N.P., Kularatne R., Whitelaw A., Chibabhai V., Naicker P., Mbelle N., Lekalakala R., Quan V., Samuel C. (2017) European Journal of Clinical Microbiology & Infectious Diseases, 36(12),2519-32.
12. Ray P., Manchanda V., Bajaj J., Chitnis D.S., Gautam V., Goswami P., Gupta V., Harish B.N., Kagal A., Kapil A., Rao R. (2013) The Indian journal of medical research, 137(2), 363.
13. Marwick C., Broomhall J., McCowan C., Phillips G., Gonzalez-McQuire S., Akhras K., Davey P. (2010) Journal of Antimicrobial Chemotherapy, 66(2), 387-397.
14. Prabhu K., Rao S., Rao V. (2011) Journal of laboratory physicians, 3(1), 25-7.
15. Fiebelkorn K.R., Crawford S.A., McElmeel M.L., Jorgensen J.H. (2003) Journal of clinical microbiology, 41(10),4740-4.
16. Mokta K.K., Verma S., Chauhan D., Ganju S.A., Singh D., Kanga A., Kumari A., Mehta V. (2015) Journal of clinical and diagnostic research, 9(8),20-3.
17. Hatkar S.S., Bansal V.P., Mariya S., Ghogare H.S. (2014) International Journal of Health Sciences and Research 4(6),99-103.
18. Spellberg B., Daum R. (2012) In Seminars in immunopathology 34(2), 335-348.
19. Wayne P.A. (2007) Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing.
20. Drew W.L., Barry A.L., O'Toole R., Sherris J.C. (1972) Applied microbiology, 24(2),240-7.
21. Shah V.P., Mundra N., Vachhani N., Shah H.Y., Gadhvi H., Shingala H. (2012) International Journal of Science and Research, 1(3),2277-9.
22. Bhattacharya S., Pal K., Jain S., Chatterjee S.S., Konar J. (2016) Journal of clinical and diagnostic research, 10(9), 32.
23. Dhanalakshmi T.A., Umapathy B.L., Mohan D.R. (2012) Journal of Academy of Medical Sciences, 2(2), 73.